Collaboration - June 4, 2015
AZ Might Consider CAR-T Firm
After AstraZeneca told Bloomberg it might be interested in a cancer therapy company, Juno Therapeutics’ stocks jumped by more than 15.3 percent this week, according to BioSpace.com. AstraZeneca’s CEO Pascal Soriot made the comments after he was asked whether his firm would be interested in a company like Juno, which develops ways the body can use its […]
Financing - October 4, 2013
Pharmalink raises SEK 96 million
The Swedish company Pharmalink has raised SEK 96 million to undertake pivotal studies with lead programs in cancer therapy and renal disease. Pharmalink, a specialty pharma company focused on orphan and niche products, today announces it has raised SEK96 million (€11m / US$15m) in a Series C financing round. The round was co-led by two […]